Emily Leproust
Vermögen: 31 Mio $ am 31.12.2025
Profil
Emily Marine Leproust gründete Twist Bioscience Corp. und Petri. Dr. Leproust hat die Position des Chairman, President & Chief Executive Officer für Twist Bioscience Corp. inne. Sie ist auch im Vorstand von CM Life Sciences, Inc. Zuvor war Dr. Leproust Chairman bei Nektar Therapeutics und Director-Applications & Chemistry bei Agilent Technologies, Inc. Dr. Leproust promovierte an der University of Houston und erwarb einen Abschluss an der Lyon School of Industrial Chemistry.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TWIST BIOSCIENCE CORP. 1,43 % | 22.12.2025 | 874.313 ( 1,43 % ) | 28 Mio $ | 31.12.2025 |
| 18.06.2025 | 21.276 ( 0,07 % ) | 3 Mio $ | 31.12.2025 |
Aktuelle Nachrichten zu Emily Leproust
Aktive Positionen von Emily Leproust
| Unternehmen | Position | Beginn |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Vorstandsvorsitzender | 01.01.2013 |
| GENEDX HOLDINGS CORP. | Direktor/Vorstandsmitglied | 01.09.2020 |
NFX Capital Management LLC
NFX Capital Management LLC NFX Capital invests in companies located in the United States, Israel, Latin America and Europe. The firm targets companies operating across a broad range of sectors and industries. The firm provides financing for pre-seed, seed and early stage capital requirements with an investment size of USD 1-5 million. | Berater | 01.02.2021 |
Pillar Co Management LLC
Pillar Co Management LLC Pillar VC invests in companies located across the globe primarily in United States. The firm focuses on broad range of sectors and industries. It participates in pre-seed and seed stage transactions with an investment size of USD 0.5 - 7 million. It acts as a lead investor and takes a seat on the board of directors. | Private Equity Investor | - |
Nuclear Threat Initiative, Inc.
Nuclear Threat Initiative, Inc. Miscellaneous Commercial ServicesCommercial Services Provides nuclear awareness | Direktor/Vorstandsmitglied | 13.10.2023 |
Ehemalige bekannte Positionen von Emily Leproust
| Unternehmen | Position | Ende |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01.04.2013 |
| SEM4 HLDG | Direktor/Vorstandsmitglied | - |
| NEKTAR THERAPEUTICS | Vorsitzender | - |
Petri
Petri Functions as an alternative investment manager | Gründer | - |
Ausbildung von Emily Leproust
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Agilent Technologies, Inc.
Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Twist Bioscience Corp.
Twist Bioscience Corp. Develops proprietary semiconductor-based synthetic DNA manufacturing process | |
University of Houston
University of Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuclear Threat Initiative, Inc.
Nuclear Threat Initiative, Inc. Miscellaneous Commercial ServicesCommercial Services Provides nuclear awareness | Commercial Services |
NFX Capital Management LLC
NFX Capital Management LLC NFX Capital invests in companies located in the United States, Israel, Latin America and Europe. The firm targets companies operating across a broad range of sectors and industries. The firm provides financing for pre-seed, seed and early stage capital requirements with an investment size of USD 1-5 million. | |
Pillar Co Management LLC
Pillar Co Management LLC Pillar VC invests in companies located across the globe primarily in United States. The firm focuses on broad range of sectors and industries. It participates in pre-seed and seed stage transactions with an investment size of USD 0.5 - 7 million. It acts as a lead investor and takes a seat on the board of directors. | |
Lyon School of Industrial Chemistry
Lyon School of Industrial Chemistry Functions as a College/University | |
Petri
Petri Functions as an alternative investment manager | |
CM Life Sciences, Inc.
CM Life Sciences, Inc. Operates as blank check company | |
GeneDx Holdings Corp.
GeneDx Holdings Corp. Provides diagnostic genetic testing services |
















